Abstracts of the 24th Annual Scientific Meeting of Indonesian Heart Association 2015 (24th ASMIHA) Jakarta, Indonesia, April 10th – 12th, 2015
Indonesian Heart Association
02 June 2015
June 2015, 23:2
1.Mclnnes GT. Hypertension and coronary artery disease: cause and effect. J Hypertens Suppl 1995; 13(2): S49–56.
2.Lawes CM, Bennett DA, Rodgers A. Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med 2002; 2(4): 355–68.
3.Boon D, Piek JJ, Montfrans GA. Silent ischemia and hypertension. Journal of Hypertension 2000; 18(10): 1355–1364.
4.Boras J, Brkljacic N, Ljubicic A, Ljubic S. Silent ischemia and diabetes mellitus. Diabetologia Croatia 2010; 39(2): 57–65.
5.Ayad F, Belhadj M, Paries J, Attali JR, Valensi P. Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications. Diabet Med 2010; 27(7): 804–811
6.Sacre JW, Jellis CL, Coombes JS, Marwick TH. Diagnostic accuracy of heart-rate recovery after exercise in the assessment of diabetic autonomic neuropathy. Diabet Med 2012; 29(9): e312–320.
7.Yamada T, Yoshitama T, Makino K, Lee T, Saeki F. Heart rate recovery after exercise is a predictor of silent myocardial ischemia in patients with type 2 diabetes. Diabetes Care 2011; 34: 724–6.
8.Polonia J, Amaral C, Bertoquini S, Martins L. Attenuation of heart rate recovery after exercise in hypertensive patients with blunting of the nighttime blood pressure fall. Int J Cardiol 2006; 106(2): 238–43.
9.Rutter MK, Wahid ST, McComb JM, Marshall SM. Significance of Silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. JACC 2002; 40(1): 56–61.
10.Beijers H, Ferreira I, Stehouwer C. Microalbuminuria and cardiovascular autonomic dysfunction are independently associated with cardiovascular mortality : Evidence for distinct pathway. Diabetes Care 2009; 32(9): 1698–1703.
11.Bianchi S, Bigazzi R, Amoroso A, Campese VM. Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity. Journal of Human Hypertension 2003; 17: 13–20.
12.Gansevoort RT, Verhave JC, Hillege HL, et al. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney International 2005; 67(94): S28–S35.
13.Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997; 6(2): S31–S37.
14.Massie BM, Szlachcic Y, Tubau JF, O’Kelly BF, Mmon S, Chin W. Scintigraphic and electrocardiographic evidence of ilent coronary artery disease in asymptomatic hypertension: A casecontrol study. JACC 1993; 22(6): 1598–1606.
15.Pringle SD, Dunn FG, Tweddel AC, Martin W, Macfarlane PW, McKillop JH, et al. Symptomatic and silent yocardial schaemia in hypertensive patients with left ventricular hypertrophy. Br Heart J 1992; 67(5): 377–382.
16.Laukkanen JA, Makikallio TH, Rauramaa R, Kurl S. Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: a population-based follow-up study. Eur Heart J 2009; 30: 558–5
17.Cheng YJ, Lauer MS, Earnest CP, et al. Heart rate recovery following maximal exercise testing as a predictor of rdiovascular disease and all cause mortality in men with diabetes. Diabetes Care 2003; 26: 2052–2057.
18.Hadley DM, Dewey FE, Freeman JV, Myers JN, Froelicher VF. Prediction of cardiovascular death using a novel heart ate recovery parameter. Med Sci Sports Exerc 2008; 40(6): 1072–9
19.Watanabe J, Thamilarasan M, Blackstone EH, Thomas JD, Lauer MS. Heart rate recovery immediately after treadmil xercise and left ventricular systolic dysfunction as predictors of mortality. Circulation 2001; 104: 1911–1916.
20.Palatini P. Prevalence and clinical correlates of microalbuminuria in stage 1 hypertension. Results from the ypertension and Ambulatory Recording Venetia Study (HARVEST) study. Am J Hypertens 1996; 9: 334–341.
21.Marin R, Rodriguez P, Tranche S, Redon J, Morales-Olivas F, Galgo A, et al. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease. J Am Soc Nephrol 2006. 17(12 suppl 3): S178–88
22.Rodicio JL, Campo C, Ruilope LM. Microalbuminuria in essential hypertension. Kidney International 1998; 54: S51–4